MARKET

HROW

HROW

Harrow Health Inc
NASDAQ
33.03
-0.07
-0.21%
Opening 13:43 09/25 EDT
OPEN
33.00
PREV CLOSE
33.10
HIGH
33.10
LOW
32.58
VOLUME
185.41K
TURNOVER
--
52 WEEK HIGH
54.85
52 WEEK LOW
28.54
MARKET CAP
1.24B
P/E (TTM)
-33.0333
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HROW last week (0914-0918)?
Weekly Report · 4d ago
Weekly Report: what happened at HROW last week (0907-0911)?
Weekly Report · 09/14 09:55
Leerink Partners Initiates Coverage of Harrow at Outperform
NASDAQ · 09/09 23:32
Harrow Price Target Announced at $45.00/Share by Leerink Partners
Dow Jones · 09/09 15:28
Harrow Initiated at Outperform by Leerink Partners
Dow Jones · 09/09 15:28
Leerink Partners Initiates Coverage On Harrow with Outperform Rating, Announces Price Target of $45
Benzinga · 09/09 15:17
Leerink bullish on Harrow, initiates with an Outperform
TipRanks · 09/09 12:20
Harrow initiated with an Outperform at Leerink
TipRanks · 09/09 10:10
More
About HROW
Harrow, Inc. is a provider of ophthalmic disease management solutions. It offers a portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in the United States, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, FLAREX, NATACYN, BYQLOVI and others. Its development-stage programs include MELT-300, H-N08, CR-01, and MELT-210. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms.

Webull offers Harrow Inc stock information, including NASDAQ: HROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HROW stock methods without spending real money on the virtual paper trading platform.